CJC-1295 (with DAC)
Growth hormone axis · By Preptide Pro editorial team · Last updated
CJC-1295 (with DAC) is a growth hormone axis peptide, and it is not FDA-approved. A synthetic GHRH analogue modified to bind albumin, which extends its time in the body. Early human studies looked at growth hormone and IGF-1 levels.
Not FDA-approvedChemistry (PubChem)
| PubChem CID | 91971820 |
|---|---|
| CAS number | 446262-90-4 |
| Molecular formula | C165H269N47O46 |
| Molecular weight | 3647.2 g/mol |
| Other names | CJC 1295, CJC-1295, CJC1295, RefChem:918751, DTXCID701513160, GRF 1-29 (CJC1295), UNII-62RC32V9N7 |
Is CJC-1295 (with DAC) FDA-approved?
Not FDA-approved. No matching NDA or BLA was found in openFDA (Drugs@FDA).
How much research is there on CJC-1295 (with DAC)?
PubMed lists 35 records for “CJC-1295”, of which 2 are tagged as human clinical trials.
| Recent study | Journal | Date |
|---|---|---|
| Detection of CJC-1295 in Equine Plasma by ELISA. | Drug Test Anal | 2026 Oct 14 |
| Peptides in urology and sexual medicine: clinical effectiveness, dosing, indications, and safety: a narrative review. | Sex Med Rev | 2026 Sep 30 |
| Peptide Supplements and Their Therapeutic Applications in Sports Medicine. | Am J Sports Med | 2026 Aug 11 |
| Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. | Sports Med | 2026 Aug |
| A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review. | J Sports Med Phys Fitness | 2026 Jul |
Sources
This is general research information, not medical advice. Check with a clinician before using any compound.